Introduction
Actin is one of the most abundant proteins in eukaryotic cells, and a major structural component of the cytoskeleton, forming networks of microfilaments in the cytoplasm of cells. The human genome contains six genes for actin (three for α-actin, one for β-actin, and two for γ-actin) (Pollard, 2016). Five recombinant antibodies (AE765, AK423, AK692, AO233 and AO234) were tested for their ability to label actin by immunofluorescence.
Materials & Methods
Antibodies: ABCD_AE765, ABCD_AK423, ABCD_AK692, ABCD_AO233 and ABCD_AO234 antibodies (http://web.expasy.org/abcd/, ABCD nomenclature) were produced by the Geneva Antibody Facility (http://unige.ch/medecine/antibodies/) as mini-antibodies with the antigen-binding scFv fused to a rabbit IgG Fc. The synthesized scFv or VHH sequences (GeneArt, Invitrogen) correspond to the sequences of the variable regions joined by a peptide linker (GGGGS)3 (Table 1). HEK293 suspension cells (growing in HEK TF medium, Xell 861-0001, supplemented with 0.1% Pluronic F68, Sigma P1300) were transiently transfected with the vector coding for the scFv-Fc or VHH-Fc. Supernatants (see Table 1 for individual yields) were collected after 4 days. The antibody AJ519, which recognizes the TAC antigen (human IL2RA, Uniprot P01589), was used as a negative control (Arsimoles et al., 2020). As positive control, a commercial anti-beta actin antibody (clone 2D4H5, Proteintech 66009-1-Ig), raised against human ACTB (Uniprot P60709), was used.
| ABCD | Clone | Epitope | Reference | Yield (mg/L) |
| AE765 | SA1A | Human actin and alpha-actinin | Victor et al., 1992 | 70 |
| AK423 | mAb 236 | Dictyostelium actin (Uniprot P07830) | Lima, 2019 | 10 |
| AK692 | Nb141 | Human ACTB, (Uniprot P60709) | Jovčevska et al., 2014 | <5 |
| AO233 | 3-1 | Human ACTB, (Uniprot P60709) | Persson et al., 2013 | 90 |
| AO234 | 3-2 | Human ACTB, (Uniprot P60709) | Persson et al., 2013 | 30 |
Antigen: HEK cells were cultured on glass coverslips (Menzel-Gläser, 22x22 mm) and grown in DMEM GlutaMAXTM (Gibco 31966) supplemented with 8% Fetal Bovine Serum (Gibco 10270).
Protocol: The whole procedure was carried out at room temperature. Cells were rinsed once with PBS, and fixed either with (i) PBS + 4% paraformaldehyde (PAF) (w/v) (Applichem A3013) for 30 min, blocked with PBS + 40 mM ammonium chloride (NH4Cl) (Applichem A3661) for 5 min, and then permeabilized in PBS + 0.2% saponin for 5 min; or (ii) methanol at -20 oC for 2 min. Fixed cells were washed once (5 min) in PBS and once with PBS + 0.2% (w/v) BSA (PBS-BSA), and incubated for 30 min with the primary antibodies (for the ABCD antibodies, final concentration 5 mg/L in PBS-Tween; for the Proteintech antibody, 0.05 mg/L). After 3 washes (10 min) with PBS-BSA, cells were incubated for 30 min with secondary goat anti-rabbit IgG conjugated to AlexaFluor-647 (1:400, Molecular Probes A21245, for the ABCD antibodies) or anti-mouse IgG conjugated to AlexaFluor-647 (1:400, Molecular Probes A21235, for the Proteintech antibody). After 3 washes (10 min) with PBS-BSA, cells were incubated for 30 min with Phalloidin-TRITC (1 µg/ml in PBS-BSA, Sigma P1951). After 3 washes (10 min) with PBS-BSA, cells were mounted on slides (Menzel-Gläser, 76x26 mm) with Möwiol (Hoechst) + 2.5% (w/v) DABCO (Fluka 33480). Pictures were taken using a Zeiss LSM700 confocal microscope, with a 63x Neofluar oil immersion objective.
Results
Fluorescent phalloidin was used as a marker to label polymerized actin filaments in PAF-fixed HEK cells (Fig. 1, in white). Four anti-actin antibodies, AE765, AK692, AO233 and AO234, label some of the same structures stained with phalloidin (Fig. 1, in cyan; zoomed-in regions, identified by arrows, can be seen in Fig. 2). They also label the cellular cytoplasm (Fig. 2, pinheads). Although this cytosolic staining may represent a background staining, it seems more likely that it is due to detection of non-polymerized actin. No staining was observed when the primary anti-TAC antibody was used as a negative control (Fig. 1, ‘Neg ctr’). In PAF-fixed HEK cells, no staining was observed with the commercial anti-actin 2D4H5 antibody, nor with AK423 (Figs. 1 and 2).
Figure 1. Actin labelling in PAF-fixed HEK cells. Labeling with AE765, AK692, AO233 and AO234 antibodies (‘anti-Actin’, in cyan) partially co-localizes with phalloidin staining (‘Phalloidin’, in white). Labeling of cytoplasmic structures not labelled by phalloidin was also seen. No labelling was observed when an unrelated primary antibody (anti-TAC AJ519) was used (‘Neg ctr’ panel). No labelling was seen with AK423 or the commercial 2D4H5 antibodies. Scale bar: 20 µm.
Figure 2. Actin labelling in PAF-fixed HEK cells. Insets from Fig. 1, showing partial co-localization of AE765, AK692, AO233 and AO234 with phalloidin (arrows) and the labelling of cytoplasmic structures not labelled by phalloidin (pinheads). Scale bar: 10 µm.
Conflict of interest
The authors declare no conflict of interest.

